<DOC>
	<DOC>NCT01022398</DOC>
	<brief_summary>The purpose of this project is to determine if Vitamin D supplementation [10,000 international units of cholecalciferol (vitamin D3) by mouth weekly] will decrease the rate of discontinuation of statin therapy due to muscle ache/pain and decrease the occurrence of muscle ache/pain due to statin therapy.</brief_summary>
	<brief_title>Vitamin D Replacement: The Effect on Statin-Related Myalgias</brief_title>
	<detailed_description />
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Patients who recently prescribed statins (in the last seven days) or who have had a recent increase in statin dose (in the last seven days) Patients aged 1989 years old Men and women (not of childbearing potential) Patients receiving statins with concomitant ezetimibe history of alcoholism or malnutrition receiving concomitant niacin, fibric acid derivatives, bile acid sequestrants, or other drugs that affect cholesterol levels</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Vitamin D3</keyword>
	<keyword>HMG-CoA reductase inhibitors (statin)-related myalgias</keyword>
</DOC>